2415643-79-5

2415643-79-5 structure
2415643-79-5 structure
  • Name: IQZ23
  • Chemical Name: IQZ23
  • CAS Number: 2415643-79-5
  • Molecular Formula: C26H29N5O2
  • Molecular Weight: 443.54
  • Catalog: Signaling Pathways Epigenetics AMPK
  • Create Date: 2020-08-09 06:52:33
  • Modify Date: 2024-01-07 14:42:19
  • IQZ23 inhibits adipocyte differentiation via AMPK pathway activation. IQZ23 exerts a high efficacy in decreasing the triglyceride level (EC50=0.033 μM) in 3T3-L1 adipocytes. IQZ23 could be used for the research of obesity and related metabolic disorders[1].

Name IQZ23
Description IQZ23 inhibits adipocyte differentiation via AMPK pathway activation. IQZ23 exerts a high efficacy in decreasing the triglyceride level (EC50=0.033 μM) in 3T3-L1 adipocytes. IQZ23 could be used for the research of obesity and related metabolic disorders[1].
Related Catalog
Target

AMPK

In Vitro IQZ23 activates AMPK pathway by modulating ATP synthase activity[1]. IQZ23 (0.3 and 1.0 μM) markedly decreases the protein level of adipogenic factors C/EBPα, PPARγ, and sterol regulatory element-binding protein 1c (SREBP-1c)) after 24 h treatment as well as the level of fatty acid synthesis related proteins fatty acid synthase (FAS), acetyl CoA carboxylase (ACC), stearoyl-CoA desaturase 1 (SCD1) after 6 days of treatment in 3T3-L1 adipocytes[1]. Western Blot Analysis[1] Cell Line: 3T3-L1 adipocytes Concentration: 0.3 and 1.0 μM Incubation Time: 24 hours Result: Decreased the protein level of adipogenic factors C/EBPα, PPARγ, and SREBP-1c.
In Vivo IQZ23 (20 mg/kg, i.p.) treatment significantly reverses high fat and cholesterol diet (HFC)- induced body weight increases and accompanying clinical symptoms of obesity in mice but without indicative toxicity[1]. IQZ23 exhibits moderate terminal elimination half-lives (rat 4.2±0.3 h) and Cmax (rat 37.1±7.0 ng/mL) following oral administration (rat 5 mg/kg)[1]. IQZ23 exhibits terminal elimination half-lives (rat 4.4±0.4 h) following intravenous administration (rat 2 mg/kg)[1].
References

[1]. Yong Rao, et al. Discovery of a Promising Agent IQZ23 for the Treatment of Obesity and Related Metabolic Disorders. Eur J Med Chem. 2020 Apr 15;192:112172.

Molecular Formula C26H29N5O2
Molecular Weight 443.54
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.